The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone

ConditionOsteoporosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRobert Jones and Agnes Hunt Orthopaedic and District NHS Trust

About this trial

1. To assess the clinical utility of trabecular bone score (TBS) on fracture risk prediction including the new version (TBS V4) and future TBS versions at the spine and hip. 2. To assess the clinical utility of TBS software as a potential treatment outcome: sensitivity to change over time and following osteoporosis therapy. 3. To compare TBS to other imaging modalities of bone structure such as quantitative computed tomography (QCT) in fracture risk prediction and response to osteoporosis therapy.

Eligibility criteria

Qualifiers

Has had a DEXA scan

Disqualifiers

Unable to complete DEXA scan

Trial design

Treatments tested in this trial

  • Trabecular bone score software

Treatment groups

No treatment groups listed

Locations

This trial has no locations